Tu1345 Efficacy and Safety of Anti-TNF Therapy for Inflammatory Bowel Disease (IBD) in Liver Transplant Recipients for Primary Sclerosing Cholangitis (PSC): A Multicenter Experience

Liver Transplant ◽

Bowel Disease ◽

Sclerosing Cholangitis ◽

Efficacy And Safety ◽

Transplant Recipients ◽

Inflammatory Bowel ◽

DOP033. Efficacy and safety of anti-TNF therapy for inflammatory bowel disease (IBD) in liver transplant recipients for primary sclerosing cholangitis (PSC): a multicenter experience.

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jju027.061 ◽

2015 ◽

Vol 9 (suppl 1) ◽

pp. S40-S40 ◽

Cited By ~ 1

Keyword(s):

Liver Transplant ◽

Bowel Disease ◽

Sclerosing Cholangitis ◽

Efficacy And Safety ◽

Transplant Recipients ◽

Inflammatory Bowel ◽

Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series

Digestive and Liver Disease ◽

10.1016/j.dld.2018.02.014 ◽

2018 ◽

Vol 50 (7) ◽

pp. 668-674 ◽

Cited By ~ 8

Author(s):

Romain Altwegg ◽

Roman Combes ◽

David Laharie ◽

Victor De Ledinghen ◽

Sylvie Radenne ◽

...

Keyword(s):

Liver Transplant ◽

Bowel Disease ◽

Sclerosing Cholangitis ◽

Case Series ◽

Transplant Recipients ◽

Inflammatory Bowel ◽

Su1855 – Vedolizumab is Not Associated with Increased Infection Risk in Immunosuppressed Liver Transplant Recipients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

Gastroenterology ◽

10.1016/s0016-5085(19)38492-6 ◽

2019 ◽

Vol 156 (6) ◽

pp. S-636

Author(s):

Chung Sang Tse ◽

Edward V. Loftus ◽

Laura H. Raffals ◽

Amy L. Lightner

Keyword(s):

Liver Transplant ◽

Bowel Disease ◽

Sclerosing Cholangitis ◽

Infection Risk ◽

Transplant Recipients ◽

Inflammatory Bowel ◽

Colonoscopy Surveillance in Liver Transplant Recipients for Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease

Transplantation Proceedings ◽

10.1016/j.transproceed.2020.01.116 ◽

2020 ◽

Vol 52 (8) ◽

pp. 2484-2486

Author(s):

Stanisław Rządkowski ◽

Agnieszka Chmielińska ◽

Marek Pacholczyk ◽

Beata Łągiewska

Keyword(s):

Liver Transplant ◽

Bowel Disease ◽

Sclerosing Cholangitis ◽

Transplant Recipients ◽

Inflammatory Bowel ◽

Colonoscopy Surveillance ◽

P474 Efficacy and safety of anti-TNF and vedolizumab in liver transplant recipients with inflammatory bowel disease (IBD)

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjx180.601 ◽

2018 ◽

Vol 12 (supplement_1) ◽

pp. S343-S344

Author(s):

C Bellanger ◽

L Beaugerie ◽

A Amiot ◽

S Tezenas du Montcel ◽

C Duvoux ◽

...

Keyword(s):

Liver Transplant ◽

Bowel Disease ◽

Efficacy And Safety ◽

Transplant Recipients ◽

Inflammatory Bowel ◽

Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2012.05217.x ◽

2012 ◽

Vol 36 (6) ◽

pp. 569-574 ◽

Cited By ~ 39

Author(s):

A. B. Mohabbat ◽

W. J. Sandborn ◽

E. V. Loftus ◽

R. H. Wiesner ◽

D. H. Bruining

Keyword(s):

Liver Transplant ◽

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Transplant Recipients ◽

Inflammatory Bowel ◽

Liver Transplant Recipients ◽

Necrosis Factor

Evolving strategies to reduce colectomy rates in primary sclerosing cholangitis-inflammatory bowel disease: clinical remission of corticosteroid refractory colitis post-liver transplant with vedolizumab

Frontline Gastroenterology ◽

10.1136/flgastro-2016-100711 ◽

2016 ◽

Vol 7 (4) ◽

pp. 271-274 ◽

Cited By ~ 2

Author(s):

Saqib Mumtaz ◽

Jason Goh ◽

Gideon M Hirschfield ◽

James Ferguson ◽

Sheldon C Cooper

Keyword(s):

Liver Transplant ◽

Bowel Disease ◽

Clinical Remission ◽

Sclerosing Cholangitis ◽

S1017 Colonoscopic Surveillance in Inflammatory Bowel Disease Post Liver Transplant for Primary Sclerosing Cholangitis

Gastroenterology ◽

10.1016/s0016-5085(09)63752-5 ◽

2009 ◽

Vol 136 (5) ◽

pp. A-814

Author(s):

Gokulan Pavendranathan ◽

Warwick Selby ◽

Nicholas A. Shackel ◽

Simone I. Strasser ◽

Geoffrey W. McCaughan ◽

...

Keyword(s):

Liver Transplant ◽

Bowel Disease ◽

Sclerosing Cholangitis ◽

Colonoscopic Surveillance ◽

Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study

Digestive and Liver Disease ◽

10.1016/j.dld.2020.09.011 ◽

2020 ◽

Author(s):

Davide Giuseppe Ribaldone ◽

Nicola Imperatore ◽

Marco Le Grazie ◽

Federica Furfaro ◽

Paola Balestrieri ◽

...

Keyword(s):

Liver Transplant ◽

Bowel Disease ◽

Sclerosing Cholangitis ◽

Disease Course ◽

Transplant Patients ◽

RETRACTED: PS 124 - Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (Psc) in Individuals with Inflammatory Bowel Disease

Journal of Hepatology ◽

10.1016/s0168-8278(16)01707-4 ◽

2016 ◽

Vol 64 (2) ◽

pp. S199 ◽

Cited By ~ 2

Author(s):

B. Eksteen ◽

J. Heatherington ◽

J. Oshiomogo ◽

R. Panaccione ◽

G. Kaplan ◽

...

Keyword(s):

Bowel Disease ◽

Sclerosing Cholangitis ◽

Efficacy And Safety ◽